跳至主要内容
临床试验/NCT05208775
NCT05208775尚未招募不适用

A Phase III, Randomized, Controlled Study of Endoscopic Submucosal Dissection Versus Photodynamic Therapy for Early Esophageal Cancer

The First Affiliated Hospital of Henan University of Science and Technology0 个研究点目标入组 46 人开始时间: 2022年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
46
主要终点
2-year disease-free survival rate

研究概览

简要总结

The purpose of this study was to compare the efficacy and safety of Photodynamic therapy (PDT) and Endoscopic submucosal (ESD) dissection in the treatment of early esophageal cancer.

详细描述

Background: Photodynamic therapy (PDT) is recommended by the NCCN guidelines as an effective method for the treatment of early esophageal cancer. However, there is no clinical trial data so far on whether its efficacy can be compared with that of standard Endoscopic submucosal (ESD). Our team will conduct a detailed study on it.

Aim: to compare the efficacy and safety of Photodynamic therapy (PDT) and Endoscopic submucosal (ESD) dissection in the treatment of early esophageal cancer.

Methods: This study intends to recruit 46 patients with early esophageal cancer and randomly divide them into two groups: one group to receive ESD and the other group to receive PDT.The efficacy and safety were observed after 2 years of follow-up.

Primary endpoints: The recurrence rates at 3 months, 6 months, and 2 years were compared.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • High-grade intraepithelial neoplasia of the esophagus
  • 18-80 years old
  • The tumor was confined to the lamina propria of the mucosa
  • The tumor invaded the submucosa and was limited to 200 microns

排除标准

  • The tumor invaded the entire circumference of the esophagus
  • The tumor invaded the muscularis or submucosa more than 200 microns
  • The patient has difficulty tolerating anesthesia due to other diseases
  • Pregnant or breastfeeding women

结局指标

主要结局

2-year disease-free survival rate

时间窗: 2 year

The percent of 2 year disease-free survival after random allocation, percent

次要结局

  • Esophageal stenosis rate at 3 months(3 months)

研究者

发起方
The First Affiliated Hospital of Henan University of Science and Technology
申办方类型
Other
责任方
Sponsor

相似试验